Julian Downward

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Julian Downward
Jan 14, 2025, 02:52 | Blog
ORACLE: A clonal-expression biomarker predicts stage I NSCLC outcome ⁦
Jarushka Naidoo shared on X: "ORACLE: A clonal-expression biomarker predicts stage I NSCLC outcome ⁦…
Jan 13, 2025, 12:46 | Opinion
5 Articles suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at…
Dec 26, 2024, 15:06 | Insight
Julian Downward: Compounds that block the interaction of RAS proteins with PI3-kinase
Julian Downward, Cancer biologist at the Francis Crick Institute, shared a post on X about…
Dec 23, 2024, 06:00 | Blog
Anirban Maitra: Targeting the PI3Ka-RAS interaction axis
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center…
Nov 4, 2024, 12:24 | Insight
Julian Downward: Mechanisms limiting responses of KRAS mutant lung cancer to KRAS inhibitors and immunotherapy
Julian Downward, Cancer biologist at the Francis Crick Institute, shared on X: “In our new…
Sep 12, 2024, 14:29 | Insight
Patrick Hwu: The mechanism behind increased IL-1 production and cancer progression
Patrick Hwu shared a post on LinkedIn: “Cancer incidence increases with age, but what is…
Apr 14, 2024, 07:35 | Drugs
Charles Swanton: What is the role of the TME in lung cancer evolution?
Charles Swanton, Professor at University College London Cancer Institute, shared on X/Twitter: "What is the role…
Apr 8, 2024, 22:24 | Insight
NSCLC's Immune Landscape: A Comprehensive Study of the Tumor Microenvironment
A recent study, “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical…
All: 8 Posts: 1 - 100
Special Coverage